Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1998-01-28
Original market date: See footnote 1
1995-12-31
Product name:
ORBENIN PWS 125MG/5ML
DIN:
02042975 Electronic product monograph is not available
Company:
WYETH-AYERST CANADA INC.
1025 Marcel Laurin Blvd.
St. Laurent
Quebec
Canada
H4R 1J6
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.16.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01CF02 CLOXACILLIN
Active ingredient group (AIG) number:See footnote5
0131306004
Active ingredient(s) See footnote8 | Strength |
---|---|
CLOXACILLIN (CLOXACILLIN SODIUM) | 125 MG / 5 ML |